EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:

Select whether you want the search to include ALL keywords, or ANY ( one or more ) of the keywords. To conduct BOOLEAN logic searches, use AND/OR/NOT and group keywords with parentheses.

Keywords:


Match keywords: All Any Boolean

Search for: Whole word Begin End Substring

Search in Docs: Infos Glossary Events News
Newsletter

Search in DB: Links Scientists Journals
Companies Materials Instruments Components

Sort by: Alphabet Relevance Date

Sort order: Increasing Decreasing

Search result:

Found 7 links's
Page 1 of 1


Identification and quantification of potential metabolites of Gd-based contrast agents
  (Last Mod.:2019-02-20 / Rating: 5.099 )

Gadolinium speciation analysis in search for the cause of nephrogenic systemic fibrosis (NSF)
  (Last Mod.:2020-12-02 / Rating: 5.085 )

Incorporation of rare earth elements in the shell of freshwater mussels as an indicator for their bioavailability from polluted river water
  (Last Mod.:2018-07-07 / Rating: 5.072 )

The behavior of Gd-based contrast agents during wastewater treatment
  (Last Mod.:2016-03-23 / Rating: 5.071 )

Speciation analysis of Gadolinium-based contrast agents using hydrophilic interaction liquid chromatography hyphenated with inductively coupled plasma-mass spectrometry by avoiding organic solvents
  (Last Mod.:2023-11-23 / Rating: 5.062 )

The retention of gadolinium in the human body following the use of gadolinium-based MRI contrast agents: a call to action for analytical chemists
  (Last Mod.:2021-09-16 / Rating: 5.040 )

Combined speciation analysis and elemental bioimaging provides new information about the retention of gadolinium in kidney following the application of some MRI contrast agents
  (Last Mod.:2023-11-26 / Rating: 4.949 )













Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )